Maria Teresa Cedena

Maria Teresa Cedena

UNVERIFIED PROFILE

Are you Maria Teresa Cedena?   Register this Author

Register author
Maria Teresa Cedena

Maria Teresa Cedena

Publications by authors named "Maria Teresa Cedena"

Are you Maria Teresa Cedena?   Register this Author

16Publications

804Reads

8Profile Views

Imaging and bone marrow assessments improve minimal residual disease prediction in multiple myeloma.

Am J Hematol 2019 Aug 9;94(8):853-861. Epub 2019 Jun 9.

Department of Hematology , Hospital Universitario 12 de Octubre, Universidad Complutense de Madrid, Departamento de Medicina, H12O CNIO Clinical Research Hematology Unit; CIBERONC, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25507DOI Listing
August 2019

Multicenter comparison of CD34+ myeloid cell count by flow cytometry in low-risk myelodysplastic syndrome. Is it feasible?

Cytometry B Clin Cytom 2018 05 6;94(3):527-535. Epub 2017 Jul 6.

Department of Hematology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cyto.b.21538DOI Listing
May 2018

Depth of Response in Multiple Myeloma: A Pooled Analysis of Three PETHEMA/GEM Clinical Trials.

J Clin Oncol 2017 Sep 12;35(25):2900-2910. Epub 2017 May 12.

Juan-Jose Lahuerta, Maria-Teresa Cedena, Joaquin Martinez-Lopez, and María-Luisa Martín-Ramos, Hospital 12 de Octubre, CIBERONC; Raquel de Paz, Hospital Universitario La Paz; Rafael Martinez, Hospital Clínico San Carlos; Adrian Alegre, Hospital Universitario La Princesa, Madrid; Bruno Paiva and Jesus F. San-Miguel, Clinica Universidad de Navarra, Centro de Investigación Médica Aplicada (CIMA), IDISNA, CIBERONC, Pamplona; Laura Rosiñol, and Joan Blade, Hospital Clínic de Barcelona, Barcelona; Maria-Belen Vidriales, Noemi Puig, Norma C. Gutierrez, Alejandro Martin, and María-Victoria Mateos, Hospital Universitario de Salamanca Instituto de Investigacion Biomedica de Salamanca (IBSAL), Centro de Investigación del Cancer (IBMCC-USAL, CSIC), CIBERONC; Alberto Orfao, Servicio General de Citometría-NUCLEOS, Centro de Investigación del Cancer (IBMCC-USAL, CSIC), IBSAL and Department of Medicine, Universidad de Salamanca, CIBERONC, Salamanca; Lourdes Cordón and Javier De la Rubia, Hospital Universitario y Politécnico La Fe; Ana-Isabel Teruel, Hospital Clínico de Valencia, Valencia; Albert Oriol, Hospital Germans Trias i Pujol, Badalona; María-Asunción Echeveste, Hospital de Donostia, San Sebastian; Felipe de Arriba, Hospital Morales Meseguer, Murcia; Miguel T. Hernandez, Hospital Universitario de Canarias, Tenerife; Luis Palomera, Hospital Universitario Lozano Blesa, Zaragoza, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.69.2517DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5568033PMC
September 2017